Filing Flows

Filing Flows › Nutex Health (NUTX) › Who owns the stock

Who owns Nutex Health (NUTX) stock

149 funds reported Nutex Health (NUTX) shares in their latest 13F filings, worth $536M in all. The largest holder is Pertento Partners LLP ($77.1M). Last quarter 86 funds added to their stakes and 38 cut them.

Largest holders of NUTX (13F)Largest holders of NUTX (13F)Pertento Partners LLP$77.1MBlackRock$69.6MVanguard Group$42.6MAmerican Century Companies$40.6MVanguard Capital Management LLC$36.9MGeode Capital Management, LLC$22.6MState Street$22.4MD. E. Shaw$16.7MUBS Group AG$13.3MWinmill$11.2M

Largest holders (13F)

FundSharesValueChangeQuarter
Pertento Partners LLP451,310$77.1Mincrease2026-06-30
BlackRock407,349$69.6Mincrease2026-06-30
Vanguard Group258,743$42.6Mincrease2025-12-31
American Century Companies237,414$40.6Mincrease2026-06-30
Vanguard Capital Management LLC215,919$36.9Mdecrease2026-06-30
Geode Capital Management, LLC132,049$22.6Mincrease2026-06-30
State Street130,836$22.4Mincrease2026-06-30
D. E. Shaw97,454$16.7Mnew2026-06-30
UBS Group AG77,912$13.3Mincrease2026-06-30
Winmill65,350$11.2Munchanged2026-06-30
Focus Partners Wealth60,881$10.4Mnew2026-06-30
Barclays46,560$9.9Mincrease2026-09-30
Millennium Management LLC52,107$8.9Mdecrease2026-06-30
Goldman Sachs Group51,244$8.8Mincrease2026-06-30
Bridgeway Capital Management, LLC46,924$8.0Mincrease2026-06-30

Nutex Health's latest quarter

Nutex Health, Q3 2026: revenue $218M (-19% year over year), operating margin 35.4%, net earnings $40.2M, operating cash flow $78.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most NUTX stock?

By the latest 13F filings: Pertento Partners LLP ($77.1M); BlackRock ($69.6M); Vanguard Group ($42.6M); American Century Companies ($40.6M); Vanguard Capital Management LLC ($36.9M).

What is the short interest in NUTX?

1,237,099 shares were sold short at the 2026-10-15 settlement, -1.07% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.